| Rosemary Ha, | |
|
39200 Paseo Padre Pkwy, Fremont, CA 94538-1616 | |
| (510) 791-0233 | |
| Not Available |
| Full Name | Rosemary Ha |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 39200 Paseo Padre Pkwy, Fremont, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235542028 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 69234 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosemary Ha, 39200 Paseo Padre Pkwy, Fremont, CA 94538-1616 Ph: () - | Rosemary Ha, 39200 Paseo Padre Pkwy, Fremont, CA 94538-1616 Ph: (510) 791-0233 |
News Archive
In dense, urban centers around the world, many people live and work in dim and narrow streets surrounded by tall buildings that block sunlight. And as the global population continues to rise and buildings are jammed closer together, the darkness will only spread.
Stress. Work. Kids. Managing a household. These are just a few of life's daily obstacles that keep people from getting enough sleep. On top of the tasks that prevent you from going to bed are the worries that keep you up once you get there, such as relationship issues, family illness or financial stress.
Pfizer's Lipitor, a blood cholesterol lowering drug, is a popular one the among general population. However now that a generic competition for the drug has arrived in the market the company has devised discounts and incentives for patients, insurers and companies that process prescriptions that will, at least for the next six months, make the brand name drug about as cheap as or cheaper than the generics.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
Merck, known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a Marketing Authorization Application (MAA) for pembrolizumab (MK-3475), the company's investigational anti-PD-1 antibody, for the treatment of advanced melanoma.
› Verified 1 days ago
Dr. Ranjit Singh Kali-rai, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45372 Whitetail Ct, Fremont, CA 94539 Phone: 510-600-5125 | |
Heumin Li, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-248-7577 | |
Rahat Katyal, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Saltillo Pl, Fremont, CA 94536 Phone: 510-796-0884 Fax: 510-562-5194 | |
Frances Tan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 779 Emerson Ct, Fremont, CA 94539 Phone: 408-966-9696 | |
Priti Chatwani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 41766 Covington Dr, Fremont, CA 94539 Phone: 510-754-6479 | |
Kandie Ann Rago, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4020 Fremont Hub, Fremont, CA 94538 Phone: 510-791-9108 | |
Sejal Parikh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3860 Decoto Rd, Fremont, CA 94555 Phone: 510-793-9798 |